NYSEMKT: AIMAim Immunotech Inc Stock Ownership - Who owns Aim Immunotech?
Insider buying vs selling
Have Aim Immunotech Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| David I. Chemerow | Director | 2026-02-05 | 2,800 | $1.23 | $3.44kBuy |
| Thomas K. Equels | CEO President | 2025-06-13 | 107 | $7.70 | $823.58Buy |
| Thomas K. Equels | CEO President | 2025-06-12 | 103 | $8.70 | $896.10Buy |
AIM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when AIM insiders and whales buy or sell their stock.
AIM Shareholders
What type of owners hold Aim Immunotech Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ted D. Kellner | 58.60% | 4,774,709 | $1.21M | Insider |
| William A. Carter | 25.97% | 2,116,170 | $535.39k | Insider |
| Iraj Eqhbal Kiani | 7.74% | 630,886 | $159.61k | Insider |
| William M. 1. Mitchell | 6.41% | 522,103 | $132.09k | Insider |
| Peter W. Rodino Iii | 4.93% | 401,762 | $101.65k | Insider |
| Stewart Appelrouth | 4.77% | 388,729 | $98.35k | Insider |
| Nancy Bryan | 3.58% | 291,882 | $73.85k | Insider |
| Steven D. Spence | 2.57% | 209,410 | $52.98k | Insider |
| Russel J. Lander | 2.55% | 207,983 | $52.62k | Insider |
| Charles Thomas Bernhardt Iii | 2.18% | 177,420 | $44.89k | Insider |
AIM vs Biotech Stocks
Aim Immunotech Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.